From March 29, 2023 to April 30, 2023, the company has repurchased 14,000 shares, representing 0.1% for $0.07 million. With this, the company has completed the repurchase of 14,000 shares, representing 0.1% for $0.07 million under the buyback announced on April 5, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -0.20% |
|
+3.09% | -10.85% |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-10.85% | 68.1M | |
+16.71% | 44.48B | |
+43.00% | 40.57B | |
-7.92% | 38.82B | |
+33.09% | 32.22B | |
-7.10% | 27.84B | |
+14.46% | 26.79B | |
+46.73% | 14.31B | |
+34.07% | 12.7B | |
-7.61% | 11.23B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.